Stille AB (STIL.ST)
SEK 184.5
(-1.07%)
SEK 184.5
(-1.07%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 87.21 Million SEK | 11.08% |
| 2022 | 79.03 Million SEK | 25.57% |
| 2021 | 62.93 Million SEK | 52.46% |
| 2020 | 41.28 Million SEK | 5.59% |
| 2019 | 39.09 Million SEK | 12.63% |
| 2018 | 34.71 Million SEK | -10.7% |
| 2017 | 38.87 Million SEK | 39.92% |
| 2016 | 27.78 Million SEK | 1.25% |
| 2015 | 27.43 Million SEK | -7.2% |
| 2014 | 29.56 Million SEK | 16.07% |
| 2013 | 25.47 Million SEK | -28.6% |
| 2012 | 35.67 Million SEK | 2.55% |
| 2011 | 34.78 Million SEK | -2.69% |
| 2010 | 35.74 Million SEK | 3.05% |
| 2009 | 34.69 Million SEK | -14.92% |
| 2008 | 40.77 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 42.9 Million SEK | 1.45% |
| 2024 Q2 | 42.29 Million SEK | 3.32% |
| 2024 Q1 | 40.93 Million SEK | 90.31% |
| 2023 Q1 | 20.29 Million SEK | 4.5% |
| 2023 Q4 | 21.5 Million SEK | 3.34% |
| 2023 FY | 87.79 Million SEK | 11.08% |
| 2023 Q2 | 21.53 Million SEK | 6.14% |
| 2023 Q3 | 20.81 Million SEK | -3.37% |
| 2022 Q1 | 20.09 Million SEK | -4.84% |
| 2022 Q2 | 19.84 Million SEK | -1.24% |
| 2022 Q3 | 19.68 Million SEK | -0.79% |
| 2022 FY | 79.03 Million SEK | 25.57% |
| 2022 Q4 | 19.41 Million SEK | -1.35% |
| 2021 Q1 | 11.03 Million SEK | 7.46% |
| 2021 Q2 | 13.27 Million SEK | 20.32% |
| 2021 FY | 62.93 Million SEK | 52.46% |
| 2021 Q3 | 17.52 Million SEK | 32.04% |
| 2021 Q4 | 21.11 Million SEK | 20.46% |
| 2020 Q3 | 11.15 Million SEK | 12.01% |
| 2020 FY | 41.28 Million SEK | 5.59% |
| 2020 Q2 | 9.95 Million SEK | 0.52% |
| 2020 Q1 | 9.9 Million SEK | -22.98% |
| 2020 Q4 | 10.26 Million SEK | -7.97% |
| 2019 Q4 | 12.86 Million SEK | 74.72% |
| 2019 FY | 39.09 Million SEK | 12.63% |
| 2019 Q3 | 7.36 Million SEK | -26.65% |
| 2019 Q2 | 10.03 Million SEK | 13.51% |
| 2019 Q1 | 8.84 Million SEK | -18.68% |
| 2018 Q4 | 10.87 Million SEK | 27.41% |
| 2018 Q3 | 8.53 Million SEK | 16.33% |
| 2018 Q2 | 7.33 Million SEK | -8.0% |
| 2018 Q1 | 7.97 Million SEK | -8.51% |
| 2018 FY | 34.71 Million SEK | -10.7% |
| 2017 Q1 | 10.98 Million SEK | 72.38% |
| 2017 FY | 38.87 Million SEK | 39.92% |
| 2017 Q3 | 8.66 Million SEK | -17.53% |
| 2017 Q4 | 8.71 Million SEK | 0.59% |
| 2017 Q2 | 10.5 Million SEK | -4.37% |
| 2016 Q1 | 7.17 Million SEK | -16.36% |
| 2016 Q2 | 6.76 Million SEK | -5.8% |
| 2016 Q4 | 6.37 Million SEK | -14.71% |
| 2016 Q3 | 7.47 Million SEK | 10.53% |
| 2016 FY | 27.78 Million SEK | 1.25% |
| 2015 Q4 | 8.58 Million SEK | 62.65% |
| 2015 Q3 | 5.27 Million SEK | -25.98% |
| 2015 Q2 | 7.12 Million SEK | 10.38% |
| 2015 Q1 | 6.45 Million SEK | -13.9% |
| 2015 FY | 27.43 Million SEK | -7.2% |
| 2014 Q4 | 7.49 Million SEK | 7.96% |
| 2014 Q1 | 7.57 Million SEK | 32.0% |
| 2014 Q2 | 7.54 Million SEK | -0.34% |
| 2014 Q3 | 6.94 Million SEK | -7.99% |
| 2014 FY | 29.56 Million SEK | 16.07% |
| 2013 FY | 25.47 Million SEK | -28.6% |
| 2013 Q4 | 5.73 Million SEK | 14.55% |
| 2013 Q3 | 5 Million SEK | -40.51% |
| 2013 Q2 | 8.42 Million SEK | 33.48% |
| 2013 Q1 | 6.3 Million SEK | -14.0% |
| 2012 FY | 35.67 Million SEK | 2.55% |
| 2012 Q2 | 10.37 Million SEK | 9.74% |
| 2012 Q3 | 8.5 Million SEK | -18.08% |
| 2012 Q4 | 7.33 Million SEK | -13.73% |
| 2012 Q1 | 9.45 Million SEK | 4.69% |
| 2011 Q4 | 9.03 Million SEK | 26.85% |
| 2011 Q1 | 9.24 Million SEK | -7.91% |
| 2011 FY | 34.78 Million SEK | -2.69% |
| 2011 Q3 | 7.12 Million SEK | -24.15% |
| 2011 Q2 | 9.38 Million SEK | 1.56% |
| 2010 Q2 | 8.3 Million SEK | -2.59% |
| 2010 Q1 | 8.52 Million SEK | -14.98% |
| 2010 Q3 | 9.24 Million SEK | 11.29% |
| 2010 Q4 | 10.03 Million SEK | 8.64% |
| 2010 FY | 35.74 Million SEK | 3.05% |
| 2009 Q1 | 8.17 Million SEK | 0.0% |
| 2009 Q3 | 7.97 Million SEK | -7.83% |
| 2009 Q2 | 8.65 Million SEK | 5.94% |
| 2009 FY | 34.69 Million SEK | -14.92% |
| 2009 Q4 | 10.02 Million SEK | 25.67% |
| 2008 Q2 | 9.42 Million SEK | -3.97% |
| 2008 Q1 | 9.81 Million SEK | 0.0% |
| 2008 FY | 40.77 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acarix AB (publ) | 82.85 Million SEK | -5.273% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 85.744% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 85.744% |
| Arcoma AB | 53.25 Million SEK | -63.785% |
| Bactiguard Holding AB (publ) | 4.96 Million SEK | -1655.263% |
| BICO Group AB (publ) | 2.84 Billion SEK | 96.938% |
| Boule Diagnostics AB (publ) | 210.44 Million SEK | 58.555% |
| CellaVision AB (publ) | 295.99 Million SEK | 70.533% |
| Clinical Laserthermia Systems AB (publ) | 68.93 Million SEK | -26.533% |
| Chordate Medical Holding AB (publ) | 1.3 Million SEK | -6562.094% |
| C-Rad AB (publ) | 3.8 Million SEK | -2195.237% |
| Duearity AB (publ) | 21.58 Million SEK | -304.072% |
| Dignitana AB (publ) | 74.73 Million SEK | -16.703% |
| Episurf Medical AB (publ) | 2.7 Million SEK | -3130.333% |
| Getinge AB (publ) | 10.75 Billion SEK | 99.189% |
| Scandinavian Real Heart AB (Publ) | 18.22 Million SEK | -378.474% |
| Iconovo AB (publ) | 63.35 Million SEK | -37.668% |
| Integrum AB (publ) | 90.57 Million SEK | 3.702% |
| Luxbright AB (publ) | 23.09 Million SEK | -277.726% |
| Mentice AB (publ) | 237.06 Million SEK | 63.208% |
| OssDsign AB (publ) | 175.6 Million SEK | 50.331% |
| Paxman AB (publ) | 133.8 Million SEK | 34.814% |
| Promimic AB (publ) | 48.55 Million SEK | -79.64% |
| Qlife Holding AB (publ) | 162.38 Million SEK | 46.289% |
| SciBase Holding AB (publ) | 69.97 Million SEK | -24.641% |
| ScandiDos AB (publ) | 61.03 Million SEK | -42.893% |
| Sectra AB (publ) | 39.06 Million SEK | -123.278% |
| Sedana Medical AB (publ) | 174.52 Million SEK | 50.026% |
| Senzime AB (publ) | 141.51 Million SEK | 38.369% |
| SpectraCure AB (publ) | 12.12 Million SEK | -619.154% |
| Vitrolife AB (publ) | 5.56 Billion SEK | 98.433% |
| Xvivo Perfusion AB (publ) | 440.92 Million SEK | 80.219% |